Maravai LifeSciences第二季度平均每股收益$（0.08）错过$（0.07）估计，销售额4，740万美元在线

Maravai LifeSciences (NASDAQ: MRVI) reported quarterly losses of $(0.08) per share which missed the analyst consensus estimate of $(0.07) by 12.68 percent. The company reported quarterly sales of $47.40 million which met the analyst consensus estimate. This is a 35.43 percent decrease over sales of $73.40 million the same period last year.